Standardized Treatment of Persistent Atrial Fibrillation (STOP-AF) A prospective Trial on the Treatment of atrial fibrillation in a specialized Atrial fibrillation Unit

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012916

Enrollment

1000

Registered

2017-08-24

Start date

2017-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.0 I48.1 I48.2 I48.3 I48.4 I48.9 I49.1 I49.2 I49.3 I49.4 I49.5 I49.8

Interventions

Group 1: Diagnostic data, Treatment data, blood samples for biobanking, Questionnaires concerning Quality of life

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who undergo Treatment in the Atrial fibrillation unit > 18 years, existence of informed consent and signed consent document

Exclusion criteria

Exclusion criteria: Patients < 18 years, patients who can't understand the study documents, patients who don't sign the informed consent form

Design outcomes

Primary

Measure	Time frame
Morbidity and Mortality (cause of death), follow up 12 months, any recurrence of arrhythmia, Major complications (Stroke, Bleeding, Myocardial infarction, pulmonary embolism)	—

Secondary

Measure	Time frame
Follow up of 30 days: cardiac complications (MACCE) Coronary artery disease, Stroke, TIA, pulmonary embolism), any recurrence of arrhythmia with Patient oriented combined endpoints, anticoagulation related complication (severe bleeding)	—

Countries

Germany

Contacts

Public ContactKarsten Bock

Universitätsmedizin Mainz

karsten.bock@unimedizin-mainz.de06131 17 7788

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026